These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 37728162)
1. Evaluating cost savings in cytotoxic leftover management: A prospective study of vial sharing and dose rounding techniques in the Moroccan National Institute of Oncology. El Baraka S; Cherif Chefchaouni A; Bourdaime A; Ouedraogo JM; Shytry O; Belahcen MJ; Rahali Y J Oncol Pharm Pract; 2024 Oct; 30(7):1152-1159. PubMed ID: 37728162 [TBL] [Abstract][Full Text] [Related]
2. Centralization impact and cost-saving study in a Moroccan hospital's centralized unit of chemotherapy preparation. Adade CA; Benabbes M; Belahcen MJ; Rahali Y J Oncol Pharm Pract; 2020 Oct; 26(7):1630-1636. PubMed ID: 32046581 [TBL] [Abstract][Full Text] [Related]
3. Assessment of the potential impact of dose rounding parenteral chemotherapy agents on cost savings and drug waste minimization. Chillari KA; Southward J; Harrigan N J Oncol Pharm Pract; 2018 Oct; 24(7):507-510. PubMed ID: 28732452 [TBL] [Abstract][Full Text] [Related]
5. Implications of dose rounding of chemotherapy to the nearest vial size. Dooley MJ; Singh S; Michael M Support Care Cancer; 2004 Sep; 12(9):653-6. PubMed ID: 14986078 [TBL] [Abstract][Full Text] [Related]
6. Financial Impact of an Automated Oncology Dose-Rounding Initiative: One-Year Analysis. Dela-Pena JC; Eschenburg KA; LaRocca VW; Patel D; Hough SM JCO Clin Cancer Inform; 2021 Aug; 5():805-810. PubMed ID: 34351786 [TBL] [Abstract][Full Text] [Related]
7. Drug wastage and costs to the healthcare system in the care of patients with non-small cell lung cancer in the United States. Hess LM; Cui ZL; Li XI; Oton AB; Shortenhaus S; Watson IA J Med Econ; 2018 Aug; 21(8):755-761. PubMed ID: 29673274 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of potential cost savings through chemotherapy and biotherapy dose-rounding at a pediatric institution. Graff JM; Cramer J; Kolb LL; Agherrabi Z; Burgess M J Oncol Pharm Pract; 2024 Jun; 30(4):705-709. PubMed ID: 37350075 [TBL] [Abstract][Full Text] [Related]
9. Rounding rituximab dose to nearest vial size. Patel S; Le A J Oncol Pharm Pract; 2013 Sep; 19(3):218-21. PubMed ID: 23114093 [TBL] [Abstract][Full Text] [Related]
11. Decreasing drug waste, reducing drug costs, and improving workflow efficiency through the implementation of automated chemotherapy dose rounding rules in the electronic health record system. Shah V; Spence A; Bartels T; Betcher J; Soefje S Am J Health Syst Pharm; 2022 Apr; 79(8):676-682. PubMed ID: 34940791 [TBL] [Abstract][Full Text] [Related]
12. Reducing Cancer Drug Cost: 3-Year Analysis of Automated Dose Rounding in Electronic Health Records. Shah VS; Irvine C; McWilliams RR; Singh P; Soefje SA JCO Oncol Pract; 2024 Aug; ():OP2300688. PubMed ID: 39102643 [TBL] [Abstract][Full Text] [Related]
13. Cost analysis of implementing a vial-sharing strategy for chemotherapy drugs using intelligent dispensing robots in a tertiary Chinese hospital in Sichuan. Liu H; Zou L; Song Y; Yan J Front Public Health; 2022; 10():936686. PubMed ID: 36211656 [TBL] [Abstract][Full Text] [Related]
14. Potential cost savings by dose down-rounding of monoclonal antibodies in a community cancer center. Copur MS; Gnewuch C; Schriner M; Tharnish M; Gonen M; McDonald M; Kezeor J; Ramaekers RC; Gauchan D; Clark D; Greenwalt L; Mickey M; Norvell M J Oncol Pharm Pract; 2018 Mar; 24(2):116-120. PubMed ID: 29284380 [TBL] [Abstract][Full Text] [Related]
15. A preliminary analysis of the reduction of chemotherapy waste in the treatment of cancer with centralization of drug preparation. Hyeda A; Costa ES Rev Assoc Med Bras (1992); 2015 Aug; 61(4):368-74. PubMed ID: 26466220 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of the dosing strategies of biologic agents and the theoretical impact of dose rounding. Lindsey S; Parsons LB; Figg LR; Rhodes J J Oncol Pharm Pract; 2018 Jan; 24(1):47-55. PubMed ID: 29251257 [TBL] [Abstract][Full Text] [Related]
17. Potential cost savings associated with dose rounding antineoplastic monoclonal agents. Francis SM; Heyliger A; Miyares MA; Viera M J Oncol Pharm Pract; 2015 Aug; 21(4):280-4. PubMed ID: 24821690 [TBL] [Abstract][Full Text] [Related]
18. An economic evaluation of vial sharing of expensive drugs in automated compounding. Baan SD; Geersing TH; Crul M; Franssen EJF; Klous MG Int J Clin Pharm; 2022 Jun; 44(3):673-679. PubMed ID: 35262838 [TBL] [Abstract][Full Text] [Related]
19. A real-world data approach to determine the optimal dosing strategy for pembrolizumab. Jang A; Nakashima L; Ng T; Fung M; Jiwani S; Schaff K; Suess J; Goncalves R; Jang D; Kuik K; Labelle S; Pow A J Oncol Pharm Pract; 2021 Apr; 27(3):635-643. PubMed ID: 32539663 [TBL] [Abstract][Full Text] [Related]
20. Quantification of Chemotherapy Drug Wastage and Incurred Financial Loss in Paediatric Cancer Care: A Cross-Sectional Study at a Tertiary Care Public Hospital in India. Ghate S; Patil S; Kadhe N; Fulsoundar R; Pawar S Cureus; 2024 Jan; 16(1):e52076. PubMed ID: 38344631 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]